Ladenburg, Germany

Peter Röttgen


 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Peter Röttgen: Pioneering Advances in Antibody Treatments

Introduction

Peter Röttgen, an esteemed inventor based in Ladenburg, Germany, has contributed significantly to the field of biotechnology with his six patents. His innovative work has been primarily focused on the development of humanized antibodies, which play a crucial role in treating various autoimmune diseases, including systemic lupus erythematosus (SLE).

Latest Patents

Röttgen's recent patents highlight his commitment to advancing therapeutic solutions. One of his notable inventions is the "Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)." This patent features a humanized or chimeric antibody or fragment that targets interleukin-10 (IL-10). Notably, this antibody can be administered to patients without causing an intolerable increase in pro-inflammatory cytokines, providing a breakthrough treatment option for SLE.

Another significant patent is focused on the "Use of antibodies for detection of IL-10." This invention involves a humanized or chimeric antibody that binds specifically to IL-10, but does not bind when IL-10 is in complex with its receptor. This particular antibody is notable for its ability to recognize IL-10 in its homodimeric form, furthering diagnostic capabilities.

Career Highlights

Throughout his career, Peter Röttgen has been associated with prominent biotech companies such as Biotest AG and Affimed Therapeutics AG. His experience at these organizations has undoubtedly influenced his innovative endeavors and provided a strong foundation for his research.

Collaborations

Röttgen's collaborative efforts have involved working alongside esteemed colleagues, including Frank Osterroth and Christoph Uherek. Their teamwork and shared knowledge have undoubtedly contributed to the success of various projects and patents throughout Röttgen's career.

Conclusion

In summary, Peter Röttgen's contributions to biotechnology, particularly in the realm of antibody treatments, demonstrate his dedication to addressing complex medical challenges. With a total of six patents, his innovative spirit continues to inspire advancements in therapeutic solutions for autoimmune diseases. As he continues to collaborate with fellow innovators, Röttgen is poised to make an even greater impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…